
In a controlled test of 12 AI models across 33 physician-written clinical cases, a clearly labeled pharmaceutical ad raised the share of responses choosing the advertised drug from 35% to 47.6%.
A discussion on optimizing the number of patients with diabetes who receive screening for diabetic retinopathy to ensure the best quality outcomes.





